Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

Cinven goes ahead with Synlab take-private

UK PE group Cinven is pushing ahead with its €10-per-share acquisition of multinational labs group Synlab by launching a public acquisition offer to all shareholders. This comes after several months of slience after Cinven made an initial non-binding offer to take the group private back in March. 

Median expands into third major European market

Waterland-owned Germany and UK rehabilitation and mental health specialist Median has expanded into a third major market with the acquisition of Hestia Alliance in Spain. HBI asks "why Spain?"

Controversial care cuts in the Netherlands on hold following fall of government

Elderly care in the Netherlands has been stuck in a state of limbo for a while now. Political upheaval over the summer and the collapse of a four-party coalition government after 18 months in power has only made the future of care - and the implementation of planned budget cuts - harder to predict. HBI chats to a consultant to find out more.

Why it pays to do the basics when building a patient pathway

A German outpatient operator tells HBI how providers are attracting and keeping patients within their businesses throughout the patient pathway, with as many as 50% of complex ophthalmology referrals coming from internal sources. HBI hears it pays to do basic (less profitable) work and even consider retail early in the patient journey so when they really do need help, they already have a provider of choice.

Hungary’s health care sector boosted by new state-of-the-art TritonLife lab

TritonLife, Hungary’s largest private hospital group, has significantly boosted the country’s diagnostic testing capacity by opening a new state-of-the-art laboratory in Budapest. The group tells HBI it will eventually have the capacity to process 10 million tests per year, including many which previously had to be sent abroad to be processed. As well as providing an in-house diagnostics service to the group’s own patients, TritonLife has agreed to provide testing services to more than 20 other private health care providers in the country.

Alliance Medical sale “imminent”

HBI hears that the longstanding sale of UK diagnostic firm Alliance Medical Group is imminent, with two bidders left in the process and pan-European operator Affidea tipped to be the front-runner. We speak to three market experts to find out more about the deal which is being valued at around $800m-$1bn.

Interview: Jim Kean, CEO, Molecular You

HBI speaks to Jim Kean, CEO of Molecular You, a North American start-up that does tests which analyse patients' proteins and metabolites (small molecules produced during metabolism) to predict what diseases they are at risk of having. Kean tells us that through the use of hundreds of biomarkers and with the help of AI, they are able to achieve a 98% predictive accuracy for certain conditions.

Interview: Michal Tzuchman Katz, CEO and founder of Kahun

The possibilities of AI in medicine are seemingly boundless, with many talking about its labour saving potential. Yet concerns persist, particularly with Chat GPT, and its black box LLM (large language model) system which is designed to mimic conversation but is not always factually accurate nor able to spot signs of acuity. By their nature, black box systems also cannot explain the conclusions they reach.

Optimo acquires Abbeycare

UK Homecare group Optimo Care is acquiring specialist supported-living provider Abbeycare, the deal marking the group’s eighth acquisition in the last year. HBI speaks to Ben Hales, Optimo’s group project director to find out more about its run of M&A in what, for most, has been a quiet year.

Find Us